Abstract
Nutritional status of AD patients is significantly compromised compared with normal controls, and tends to be worsened with AD progresses. Early identification and intervention of individuals with nutritional risk or malnutrition may be significantly beneficial for reducing the risk, development, and progression of AD.
Introduction
While Alzheimer’s disease (AD) remains incurable, researchers are increasingly focusing on modifiable risk factors to slow its progression. Malnutrition is a known complication of AD, linked to faster cognitive decline and higher mortality. However, a "gold standard" for holistically evaluating nutritional status across different disease stages has been lacking. This study investigates specific nutritional indices—ranging from dietary patterns and body composition to blood-based laboratory variables—to determine their association with AD progression and their utility in distinguishing between healthy individuals, those with mild cognitive impairment (MCI), and those with AD dementia.
Methods and Datasets
The researchers conducted a cross-sectional study at Beijing Tiantan Hospital, enrolling participants between April 2019 and April 2023. The final cohort of 266 subjects was categorized into three groups: Normal Cognition (NC, n=73), MCI due to AD (AD-MCI, n=72), and Dementia due to AD (AD-D, n=121).
Data collection included body composition (BMI and circumferences), dietary patterns (Mediterranean and MIND diet scores), standardized nutritional scales (MNA and GNRI), and 22 blood biomarkers. Binary logistics regression identified independent associations, while Receiver Operating Characteristic (ROC) curves measured diagnostic effectiveness.
Key Insights
- Dietary Patterns vs. Nutritional Status: Surprisingly, Mediterranean or MIND diet scores did not differ significantly between groups. This suggests that in clinical stages of AD, actual nutritional absorption and body composition may be more indicative of status than current dietary patterns.
- The Importance of Muscle Mass: Hip and calf circumferences were more significant indicators than BMI alone, highlighting "sarcopenia" (muscle loss) as a critical component of AD-related decline.
- Protein Biomarkers: Lower levels of total protein, albumin, and globulin were strongly associated with disease severity. Albumin emerged as the strongest single blood marker for early-stage detection.
Key Results
The study demonstrated that nutritional status significantly deteriorates as AD progresses. Binary logistic regression revealed several nutrition-related variables as independent risk factors.
- Diagnostic Accuracy: Combining different data types significantly boosted accuracy. For distinguishing AD from healthy controls, a model combining total protein, albumin, calf circumference, and MNA scores achieved an AUC of 0.83.
- Early Detection (NC vs. AD-MCI): A combination of albumin, hip circumference, and GNRI score reached an AUC of 0.76.
- Progression Tracking (AD-MCI vs. AD-D): The MNA score combined with calf circumference and homocysteine levels reached an AUC of 0.77.
Discussion and Limitations
This cross-sectional study provides a "snapshot" showing strong associations between nutritional decline and AD progression, though it cannot prove causality. The reliance on self-reported dietary data introduces potential memory bias. Future longitudinal studies are needed to track these markers over time and explore biological mechanisms, such as the interaction between albumin and amyloid-beta (Aβ).
Summary updated